Publications by authors named "Emilio Albamonte"

Claim this Profile
H
Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibition.
Mariarita Bertoldi, Emilio Albamonte, Luca Bello, Adele D'amico, Riccardo Masson

Clin Epigenetics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Nucleotide Variants in a Cohort of Individuals With Spinal Muscular Atrophy.
Martina Rimoldi, Francesca Magri, Megi Meneri, Delia Gagliardi, Valeria Ada Sansone, Emilio Albamonte

Neurol Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper limb progression in Duchenne muscular dystrophy: Insights from a 36-month longitudinal study using the PUL 20.
Giorgia Coratti, Marika Pane, Sophia Paolucci, Luca Bello, Adele D'Amico, Emilio Albamonte

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data.
Emilio Albamonte, Adrea Lizio, Giorgia Coratti, Lorenzo Maggi, Elena Pegoraro

Neurol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen.
Giorgia Coratti, Francesca Bovis, Marika Pane, Amy Pasternak, Emilio Albamonte

Eur J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy.
Luca Bello, Pietro Riguzzi, Emilio Albamonte, Guja Astrea, Roberta Battini

Drugs R D· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity.
Domenico Gorgoglione, Daniele Sabbatini, Pietro Riguzzi, Giuliana Capece, Marika Pane, Emilio Albamonte

Brain· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1.
Federica Trucco, Emilio Albamonte, Marika Pane, Federica Ricci, Adele D'amico

Dev Med Child Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale Expanded.
Giorgia Coratti, Francesca Bovis, Maria Carmela Pera, Matthew Civitello, Annemarie Rohwer, Emilio Albamonte

Eur J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey.
Anna Capasso, Gianpaolo Cicala, Martina Ricci, Marika Pane, Adele D'Amico, Emilio Albamonte

Eur J Pediatr· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016.
Maria Carmela Pera, Giorgia Coratti, Marika Pane, Riccardo Masson, Valeria Ada Sansone, Emilio Albamonte

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study.
Marika Pane, Giulia Stanca, Giorgia Coratti, Adele D' Amico, Valeria Ada Sansone, Emilio Albamonte

Eur J Pediatr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module.
Giorgia Coratti, Matthew Civitello, Annemarie Rohwer, Emilio Albamonte, Jacqueline Montes

Neuromuscul Disord· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy.
Chiara Panicucci, Eray Sahin, Martina Bartolucci, Sara Casalini, Noemi Brolatti, Emilio Albamonte

Cell Mol Life Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy.
Federica Trucco, Andrea Lizio, Elisabetta Roma, Alessandra di Bari, Francesca Salmin, Emilio Albamonte

J Clin Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
Giorgia Coratti, Francesca Bovis, Maria Carmela Pera, Mariacristina Scoto, Jacqueline Montes, Emilio Albamonte

Eur J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.
Giorgia Coratti, Matthew Civitello, Annemarie Rohwer, Francesca Salmin, Allan M Glanzman, Emilio Albamonte

Neuromuscul Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3.
Federica Trucco, Deborah Ridout, Harriet Weststrate, Mariacristina Scoto, Annemarie Rohwer, Emilio Albamonte

Neurol Clin Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3.
Amy Wolfe, Georgia Stimpson, Danielle Ramsey, Giorgia Coratti, Sally Dunaway Young, Emilio Albamonte

J Neuromuscul Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.
Luca Bello, Daniele Sabbatini, Aurora Fusto, Domenico Gorgoglione, Giovanni Umberto Borin, Emilio Albamonte

J Neuromuscul Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study.
Giorgia Coratti, Marika Pane, Claudia Brogna, Adele D'Amico, Elena Pegoraro, Emilio Albamonte

Neuromuscul Disord· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach.
Federica Trucco, Francesca Salmin, Andrea Lizio, Giorgia Coratti, Emilio Albamonte

Dysphagia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment?
Bianca Buchignani, Gianpaolo Cicala, Federica Moriconi, Martina Ricci, Anna Capasso, Emilio Albamonte

Neuromuscul Disord· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregivers' Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study.
Maria Carmela Pera, Giorgia Coratti, Jacopo Casiraghi, Chiara Bravetti, Alessandro Fedeli, Emilio Albamonte

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies.
Marika Pane, Beatrice Berti, Anna Capasso, Giorgia Coratti, Antonio Varone, Emilio Albamonte

EClinicalMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis